Summary: Researchers are investigating links between the gut microbiome and Alzheimer’s disease. Emerging evidence suggests that toxic metabolites produced by harmful gut bacteria may reach the brain, cause inflammation, and contribute to the development and progression of dementia.
This line of research aims to identify the specific microbial metabolites and pathways that damage neurons, to support the development of targeted drug therapies that block or neutralize those molecules. The team is also testing whether probiotics and targeted nutritional supplements can restore a healthy microbiome, reduce harmful metabolites, and potentially prevent or slow Alzheimer’s progression.
Key Facts:
- Harmful gut bacteria may contribute to the onset and acceleration of Alzheimer’s disease.
- Diet, aging, inactivity, environmental exposures and genetics influence gut health and microbiome balance.
- Probiotics and nutritional supplements are being explored as strategies to rebalance the microbiome and protect the brain.
Source: University of South Australia
The adage “you are what you eat” has long implied a link between diet and bodily health. Recent research now strengthens the case that diet and age also influence brain health through effects on the gut microbiome.
A growing body of studies points to an association between Alzheimer’s disease and an imbalanced gut microbiome. Australian scientists are expanding on that evidence by investigating how harmful bacteria in the gut may produce metabolites that reach the brain and contribute to dementia-related changes.
University of South Australia nano bio-scientist Dr. Ibrahim Javed explains that small molecules released by pathogenic gut bacteria—commonly called metabolites—can potentially travel beyond the gut and trigger inflammatory responses in the brain. That inflammation is one of the hallmarks associated with neurodegeneration in Alzheimer’s disease, for which effective cures do not currently exist.
In younger individuals, the blood-brain barrier more effectively limits exposure of the brain to circulating toxins and pathogens. However, with aging the integrity of this barrier can decline, increasing the brain’s vulnerability to harmful substances. At the same time, aging and lifestyle factors can disrupt the gut microbiome, reducing its resilience and increasing the production of detrimental metabolites.
A principal objective of the three-year research project is to identify the metabolites and mechanisms by which harmful gut microbes damage neurons. By pinpointing these pathways, researchers hope to develop novel drug approaches that block or neutralize specific metabolites, thereby slowing or halting disease progression.
A complementary aim is to evaluate whether probiotics and targeted nutritional supplements—containing beneficial bacterial strains or prebiotic compounds—can suppress pathogenic microbes, reduce the formation of harmful metabolites, and restore a healthier gut environment that is less likely to impact brain health.
This work builds on international clinical studies that have shown probiotics can improve digestive health and, in some cases, cognitive symptoms linked to acute and long-term effects of infections such as COVID-19. While those studies do not prove a direct cure for neurodegeneration, they encourage further investigation into how modulating the microbiome may support brain function.
An unhealthy diet is a key, modifiable factor that can accelerate the risk of developing Alzheimer’s disease by promoting an imbalance in gut microbes. Other contributors include aging, physical inactivity, exposure to environmental toxins such as certain pesticides, and genetics—although genetic causes account for a minority of cases. In many instances, lifestyle and environmental factors are potentially preventable or manageable.
“Our research suggests that harmful gut bacteria can contribute to early-onset dementia as well as worsen dementia in people already living with the disease,” Dr. Javed says. “Addressing gut health through diet, exercise, and possibly targeted microbial therapies may offer a valuable strategy to reduce risk or slow progression.”
Most bacteria are benign or beneficial and play essential roles in digestion, immune function and overall health. However, pathogenic strains can form protective biofilms and produce toxins that are linked to gastrointestinal infections, chronic inflammatory conditions, certain cancers and, increasingly, to neuroinflammatory processes implicated in brain disease.
Alzheimer’s disease currently affects tens of millions of people worldwide, and with global population aging, prevalence is expected to grow substantially over coming decades. Cases of early-onset dementia (diagnosed under age 65) are also rising, often associated with preventable risk factors such as poor diet, sedentary behavior, smoking, excessive alcohol use, social isolation and environmental pollution.
Dr. Javed’s team is collaborating with UniSA neuroscientist Associate Professor Larisa Bobrovskaya to explore whether chronic stress contributes to Alzheimer’s risk and to investigate sex differences in vulnerability, including whether women may be at greater risk under certain conditions.
About this Alzheimer’s disease and microbiome research news
Author: Ibrahim Javed
Source: University of South Australia
Contact: Ibrahim Javed – University of South Australia
Image: The image is credited to Neuroscience News